Skip to Main Content

Paper Details

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
J Clin Invest
18
2022
7HP349, CD8+, CD8+ Teff, CD8+ effector T cells, CTLA-4, CXCL12, CXCL12 gene, LFA-1, PD-1, RNA, T cell, T cells, Teffs, VLA-4, anti, anti-CTLA-4, anti-PD-1-resistant) tumors, anti-programmed death 1-resistant (, anti-programmed death 1-resistant (anti-PD-1-resistant) tumors, cancer, innate immune cells, integrins, lymphocyte function-associated antigen-1, melanoma, neutrophils, patients, programmed death 1, tumor, tumor cells, tumor-specific T cells, very late activation antigen-4

Datasets

Release 1.2